Medicine summary - citalopram (to end January 2009)

Similar documents
MEDICINE SUMMARY. CHLORPROMAZINE HYDROCHLORIDE Layer 1 of 1 ALL REPORT DATES. Febrile neutropenia. Lymphadenopathy. Thrombocythaemia.

Medicine summary - Antipsychotics- chlorpromazine

Medicine summary - Antipsychotics- haloperidol

MEDICINE SUMMARY. Atomoxetine Hydrochloride Layer 1 of 8 ALL REPORT DATES. Tachycardia. Supraventricular tachycardia. Palpitations.

Summary listing of suspected adverse reactions and events associated with use of Gardasil 01/06/ /12/2015

Suspected Adverse Reaction Analysis. CERVARIX Human papillomavirus (HPV) vaccine

Case Series Drug Analysis Print Name: Vaxigrip, Fluarix, Inflexal V og Influenzacvaccine 01Sep Oct2014

Case Series Drug Analysis Print Name: Isotretinoin

Continence PGD - Oxybutynin 5mg Modified Release

Adverse events following immunisation (AEFI) with 2010/2011 seasonal influenza vaccines

Database of Adverse Event Notifications - medicines

Nausicalm solution for injection is a clear colourless solution, presented in 1 ml ampoules.

Study No.: Title: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

Core Safety Profile. Pharmaceutical form(s)/strength: Immediate release tablets 1 mg, 2 mg, 4 mg and 8 mg (IR) Date of FAR:

Pharmaceutical form(s)/strength: Powder for solution for injection/prefilled syringe, 20mg UK/H/PSUR/0027/002 Date of FAR:

GLOSSARY OF MEDICAL TERMS IN LAY LANGUAGE

CORE SAFETY PROFILE OXYCODONE HYDROCHLORIDE NL/H/PSUR/0054/ January 2013

Core Safety Profile. Pharmaceutical form(s)/strength: Sterile eye drops 1%, 2% Date of FAR:

Lessons learnt from Influenza A(H1N1) vaccines benefit-risk monitoring

Summary details of suspected adverse reactions/events associated with the use of Gardasil 1st March st March 2015

U.S. Department of Health and Human Services Food and Drug Administration Center for Food Safety and Applied Nutrition

Pharmaceutical form(s)/strength: Solution: 5 mg/ml Suspensions: 2.5 and 5 mg/ml P-RMS:

PFIZER INC. THERAPEUTIC AREA AND FDA APPROVED INDICATIONS: See United States Package Insert (USPI)

Core Safety Profile. Pharmaceutical form(s)/strength: Capsules, 0.5 mg AT/H/PSUR/0028/001 Date of FAR:

Database of Adverse Event Notifications - medicines

Core Safety Profile. Pharmaceutical form(s)/strength: Prolonged release tablets, 4 mg and 8 mg (GITS) Date of FAR:

Medical History Form

Headache Follow-up Visit Form

Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis

Medication is just part of the management of these illnesses. Other therapies are also helpful; you may wish to discuss these with your prescriber.

Pregabalin (Prepentin)

Core Safety Profile. Pharmaceutical form(s)/strength: Capsules, Tablets / 5 mg, 10 mg ES/H/PSUR/0013/001 Date of FAR:

Each hard capsule contains 25 mg, 50 mg, 75 mg, 100 mg or 150 mg of pregabalin.

Pharmaceutical form(s)/strength: 50, 100, 200, 400 mg tablets P-RMS:

Core Safety Profile Triptorelin 1-month/3-month formulation ATC-code: L02A E 04 March 2010

Please list any treatments you have previously had for current illness. (Physical Therapy, Surgery, Radiation, etc.)

M0BCore Safety Profile

CECILIA P MARGRET MD PhD MPH Child, Adolescent and Adult Psychiatry NE 24th ST Suite 104, Bellevue WA 98007, Phone / Fax: +1 (425)

NORTHERN VIRGINIA PULMONARY AND CRITICAL CARE ASSOCIATES, P.C.

M0BCore Safety Profile. Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg FR/H/PSUR/0066/001 Date of FAR:

Pharmaceutical form(s)/strength: Capsules, 200mg, 400mg, Oral suspensions, 90mg/5ml, 180mg/5ml, 36 mg/ml SI/H/PSUR/0002/002 Date of FAR:

Nilotinib AEs (adverse events) in CML population:

MabThera. SC. The wait is over. MabThera delivered in just 5 minutes. SC= subcutaneous injection

PATIENT HEALTH QUESTIONNAIRE Radiation Oncology

PATIENT HEALTH QUESTIONNAIRE Radiation Oncology

+ Color Change - + Hearing Loss - + Apnea - + Enuresis (urine - + Tremors - + Rash -

Cetirizine Proposed Core Safety Profile

GLUCOSE TESTING-BLOOD

New Patient Form. Patient Demographics. Emergency Information. Employment Information. Page 1 of 7. Family Health Chiropractic Care

Azathioprine toxicity criteria and severity descriptors for the listing of biological agents for rheumatoid arthritis on the PBS

Episodes of Care Risk Adjustment

Treatment of Alzheimer s disease

Past Medical History. Chief Complaint: Patient Name: Appointment Date: Page 1

Case Series Drug Analysis Print Name: Gardasil

Supplementary materials for:

Joseph S. Weiner, MD, PC Patient History Form

M0BCore Safety Profile. Pharmaceutical form(s)/strength: several forms and strength DE/H/PSUR/0039/001 Date of FAR:

1.1. An overview of reports on agomelatine

T- Timing- concise vs. complete and thorough, depending on need of presenter and audience. E- Elicit- ask for feedback- more information needed? Less?

0BCore Safety Profile. Pharmaceutical form(s)/strength: Losec MUPS tablets 10, 20 mg (OTC) NL/H/PSUR/0058/001 Date of FAR:

EVIDENCE-BASED VITAMIN AND MINERAL USAGE SUMMARY TABLE (APRIL 2002)

PERSONAL MEDICAL AND FAMILY HISTORY Please check applicable boxes.

Initial Consultation

2014 NATIONAL COVERAGE DETERMINATION (NCD) CPT CODE(S): 84436, 84439, 84443, THYROID TESTING DESCRIPTION

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

MYLAN-RIVASTIGMINE PATCH 5 Rivastigmine Transdermal Patch Each patch of 5 cm 2 contains 9 mg rivastigmine base, in vivo release rate of 4.6 mg/24 h.

Complete the CE Checklist for Customized Symptoms. Page 1 of 6

Venlafaxine hydrochloride extended-release and other antidepressant medicines may cause serious side effects, including:

Supplementary Online Content

Drugs used in obstetrics

PROFESSIONAL INFORMATION

Essential Wellness Of Illinois, LLC Health History Questionnaire Christine A. Renz L.Ac., Dipl OM, MSTOM

Core Safety Profile chlorprothixene /Truxal tablets 5 mg, 15 mg, 25 mg, 50 mg, 100 mg

Package leaflet: Information for the user. Pregabalin Kern Pharma 75 mg hard capsules

UK Suspected Adverse Drug Reaction (ADR) Analysis

Patient Information VERSACLOZ (VER sa kloz) (clozapine) Oral Suspension

Scottsdale Family Health

P-RMS: FR/H/PSUR/0036/001

Sick Call Screener Course

0BCore Safety Profile. Pharmaceutical form(s)/strength: Gastro-resistant capsules (10, 20, 40 mg) NL/H/PSUR/0058/001 Date of FAR:

Buserelin Non European. European Economic Area

Core Safety Profile. Pharmaceutical form(s)/strength: Film-coated tablets 1.25 mg, 2.5 mg, 3.75 mg, 5 mg, 7.5 mg and 10 mg. Date of FAR:

Charles Khouri, PharmD; Marion Lepelley, PharmD; Matthieu Roustit, PharmD; François Montastruc, MD; Marc Humbert, MD; and Jean-Luc Cracowski, MD

patient group direction

1.1. An overview of reports on sitagliptin

Package leaflet: Information for the user. LETROKS, 2,5 mg, film-coated tablets Letrozolum

Supplementary Online Content

Patient Intake Form. Name: Date of Birth: Social Security No.: Address: City: State: Zip:

Package leaflet: Information for the user. Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride

ANTI-DEPRESSANT MEDICATIONS

What do you believe is causing your most important health concern?

CSP Nabumetone ES/H/PSUR/0014/001. January 2010

OXYSPAS Tablets (Oxybutynin chloride)

4.4 Special warnings and precautions for use

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Continence PGD transdermal oxybutynin Kentera patch 36mg

0BCore Safety Profile

GLUCOSE TESTING-BLOOD

Transcription:

734 13 493 Blood and lymphatic system disorders Iron deficiency anaemia 1 0 1 Anaemia 1 0 1 Pancytopenia 2 0 0 Thrombocytopenia 3 0 2 Lymphadenopathy 1 0 1 Eosinophilia 2 0 1 Leukocytosis 1 0 0 Leukopenia 3 0 1 Neutropenia 4 0 1 Blood and lymphatic system disorders 18 0 8 Cardiac disorders Atrioventricular block 1 0 0 Arrhythmia 1 0 0 Bradycardia 4 0 4 Extrasystoles 1 0 1 Tachycardia 16 0 9 Arrhythmia supraventricular 1 0 1 Sick sinus syndrome 1 0 1 Sinus bradycardia 1 0 1 Supraventricular tachycardia 1 0 0 Cardiac arrest 3 2 1 Torsade de pointes 3 1 1 Ventricular tachycardia 1 0 0 Cyanosis 1 1 0 Palpitations 23 0 18 Myocardial infarction 1 0 0 Myocardial ischaemia 1 1 1 Cardiomyopathy 1 1 0 Cardiac disorders 61 6 38 Congenital, familial and genetic disorders Ventricular hypoplasia 1 1 1 Ventricular septal defect 1 0 0 Fallot's tetralogy 1 0 0 Congenital anomaly 1 1 1 Congenital, familial and genetic disorders 4 2 2 Ear and labyrinth disorders Ear pain 1 0 1 Deafness unilateral 1 0 1 Hearing impaired 1 0 1 Hyperacusis 1 0 1 Tinnitus 5 0 5 Vertigo 1 0 1 Ear and labyrinth disorders 10 0 10 Endocrine disorders Hyperprolactinaemia 2 0 1 25/09/2009-1 - 10:31:03 AM

Endocrine disorders Inappropriate antidiuretic hormone secretion 13 0 11 Endocrine disorders 15 0 12 Eye disorders Eye pain 2 0 1 Eye swelling 2 0 2 Glaucoma 3 0 2 Conjunctival haemorrhage 1 0 1 Keratitis 1 0 1 Blepharospasm 1 0 1 Strabismus 1 0 1 Mydriasis 6 0 4 Photophobia 1 0 1 Accommodation disorder 2 0 1 Diplopia 3 0 2 Photopsia 1 0 1 Vision blurred 7 0 6 Visual impairment 16 0 14 Eye disorders 47 0 38 Gastrointestinal disorders Abdominal hernia 1 0 1 Anorectal disorder 1 0 1 Tooth disorder 1 0 0 Toothache 1 0 1 Tooth discolouration 1 0 0 Gingivitis 1 0 1 Gingival bleeding 1 0 1 Pancreatitis 1 0 0 Rectal haemorrhage 1 0 0 Gastrointestinal haemorrhage 2 1 0 Haematemesis 3 0 2 Melaena 2 1 0 Colitis 1 0 0 Gastritis 3 1 1 Crohn's disease 1 0 1 Diarrhoea 36 0 25 Constipation 3 0 2 Gastrointestinal motility disorder 1 0 1 Ileus paralytic 2 0 0 Dyspepsia 6 0 6 Eructation 1 0 1 Abdominal distension 3 0 3 Flatulence 7 0 6 Abdominal pain 14 0 9 Abdominal pain upper 4 0 3 25/09/2009-2 - 10:31:03 AM

Gastrointestinal disorders Abdominal discomfort 1 0 1 General disorders and administration site conditions Breath odour 2 0 1 Dysphagia 3 0 2 Nausea 96 0 69 Vomiting 33 0 22 Intestinal obstruction 2 0 0 Duodenal ulcer 1 0 0 Lip oedema 1 0 1 Lip swelling 4 0 2 Hypoaesthesia oral 1 0 1 Oral discomfort 1 0 1 Mouth ulceration 2 0 2 Dry mouth 15 0 12 Salivary hypersecretion 1 0 0 Glossitis 1 0 1 Swollen tongue 2 0 1 Gastrointestinal disorders 264 3 181 Hypothermia 1 0 1 Pyrexia 13 0 7 1 1 0 Sudden death 3 3 0 Asthenia 6 0 5 Fatigue 26 0 18 Malaise 12 0 9 Gait disturbance 6 0 2 Condition aggravated 1 0 0 Influenza like illness 2 0 2 Irritability 4 0 3 Swelling 1 0 1 Face oedema 4 0 4 Generalised oedema 3 0 2 Oedema 3 0 1 Oedema peripheral 3 0 3 Chest pain 12 0 9 Pain 4 0 4 Chest discomfort 3 0 2 Chills 2 0 1 Feeling abnormal 2 0 1 Feeling cold 1 0 0 Feeling hot 2 0 0 Feeling jittery 2 0 1 Thirst 3 0 2 25/09/2009-3 - 10:31:03 AM

General disorders and administration site conditions Drug interaction 3 0 0 Drug ineffective 14 0 13 Drug tolerance increased 1 1 0 Therapeutic response decreased 1 0 1 Therapeutic response unexpected 1 0 1 Drug withdrawal syndrome 2 0 2 Drug withdrawal syndrome neonatal 3 0 3 General disorders and administration site conditions 145 5 98 Hepatobiliary disorders Vanishing bile duct syndrome 2 0 2 Hepatitis cholestatic 4 0 3 Jaundice 2 0 1 Jaundice cholestatic 1 0 1 Liver disorder 1 0 1 Hepatic function abnormal 1 0 1 Hepatic failure 1 0 1 Hepatomegaly 1 0 0 Hepatitis 3 0 0 Hepatobiliary disorders 16 0 10 Immune system disorders Hypersensitivity 1 0 1 Immune system disorders 1 0 1 Infections and infestations Vaginal infection 1 0 1 Infection 1 0 1 Bronchitis 1 0 1 Pneumonia 2 0 1 Rash pustular 1 0 1 Pharyngitis 2 0 2 Rhinitis 3 0 3 Sinusitis 1 0 1 Upper respiratory tract infection 2 0 2 Herpes simplex 1 0 1 Influenza 1 0 1 Infections and infestations 16 0 15 Injury, poisoning and procedural complications Drug exposure during pregnancy 4 2 2 Fall 3 0 1 Contusion 3 0 2 Intentional overdose 2 0 2 Overdose 4 0 2 Injury, poisoning and procedural complications 16 2 9 Investigations Electrocardiogram QT prolonged 4 0 1 Electrocardiogram T wave inversion 1 0 0 25/09/2009-4 - 10:31:03 AM

Investigations Electrocardiogram abnormal 1 0 0 Blood pressure increased 2 0 1 Blood creatine phosphokinase increased 6 0 1 Prothrombin time prolonged 1 0 0 Gamma-glutamyltransferase increased 1 0 1 Liver function test abnormal 5 0 1 Oxygen saturation decreased 1 0 1 Blood glucose decreased 1 0 0 Blood glucose increased 1 0 1 Electroencephalogram abnormal 1 0 0 Apgar score low 1 0 1 Respiratory rate increased 1 0 0 Weight decreased 11 0 9 Weight increased 5 0 4 C-reactive protein increased 1 0 1 Blood creatinine increased 1 0 1 Drug level decreased 1 0 0 Drug level increased 4 2 0 Investigations 50 2 23 Metabolism and nutrition disorders Decreased appetite 11 0 8 Musculoskeletal and connective tissue disorders Tetany 2 0 0 Hypomagnesaemia 1 0 0 Electrolyte imbalance 1 0 0 Polydipsia 1 0 1 Hyperkalaemia 3 0 2 Hypokalaemia 3 0 1 Hypernatraemia 2 0 2 Hyponatraemia 64 0 33 Dehydration 2 0 1 Alcohol intolerance 1 0 0 Diabetes mellitus 1 0 0 Hyperinsulinaemia 2 0 2 Hypoglycaemia 1 0 1 Hypoglycaemia neonatal 1 0 1 Metabolism and nutrition disorders 96 0 52 Exostosis 1 0 1 Bone pain 1 0 1 Sjogren's syndrome 1 0 1 Arthralgia 4 0 4 Joint stiffness 1 0 1 Myalgia 13 0 11 Muscle spasms 4 0 4 25/09/2009-5 - 10:31:03 AM

Musculoskeletal and connective tissue disorders Neoplasms benign, malignant and unspecified (incl cysts and polyps) Muscle twitching 6 0 4 Muscle rigidity 3 0 0 Trismus 2 0 2 Muscular weakness 1 0 1 Rhabdomyolysis 1 0 0 Musculoskeletal stiffness 1 0 0 Back pain 3 0 2 Pain in extremity 1 0 1 Musculoskeletal and connective tissue disorders 43 0 33 Langerhans' cell granulomatosis 1 0 1 Lymphoma 1 0 0 Neoplasms benign, malignant and unspecified (incl cysts and polyps) 2 0 1 Nervous system disorders Cerebral haemorrhage 1 0 0 Cerebrovascular disorder 1 0 1 Drug withdrawal headache 1 0 1 Headache 43 0 31 Migraine 3 0 2 Brain oedema 1 0 1 Dementia 1 0 0 Amnesia 6 0 5 Memory impairment 2 0 2 Cognitive disorder 1 0 0 Disturbance in attention 8 0 7 Chorea 1 0 0 Akathisia 5 0 3 Bradykinesia 1 0 1 Clumsiness 1 0 1 Dyskinesia 4 0 1 Extrapyramidal disorder 7 0 6 Hyperkinesia 5 0 4 Hypokinesia 3 0 0 Tardive dyskinesia 3 0 1 Dystonia 8 0 5 Opisthotonus 1 0 1 Paresis 1 0 0 Tremor 48 0 30 Hyperreflexia 6 0 2 Ataxia 5 0 3 Balance disorder 1 0 0 Coordination abnormal 5 0 4 25/09/2009-6 - 10:31:03 AM

Nervous system disorders Nystagmus 2 0 0 Pregnancy, puerperium and perinatal conditions Coma 4 0 3 Coma hepatic 1 0 1 Aphasia 1 0 0 Consciousness fluctuating 3 0 1 Depressed level of consciousness 4 0 2 Lethargy 4 0 3 Loss of consciousness 5 0 2 Sedation 1 0 0 Somnolence 20 0 12 Syncope 12 1 6 Dizziness 34 0 24 Myoclonus 6 0 1 Crying 2 0 2 Burning sensation 2 0 2 Formication 2 0 2 Paraesthesia 23 0 20 Ageusia 2 0 2 Dysgeusia 2 0 2 Hypoaesthesia 7 0 6 Restless legs syndrome 1 0 1 Sensory disturbance 1 0 1 Dysarthria 7 0 4 Speech disorder 1 0 1 Hypertonia 14 0 6 Neuroleptic malignant syndrome 4 0 0 Serotonin syndrome 35 0 10 Muscle contractions involuntary 1 0 1 Myasthenic syndrome 2 0 2 Neuropathy peripheral 1 0 1 Grand mal convulsion 5 0 4 Convulsion 23 0 13 Epilepsy 1 0 0 Nervous system disorders 406 1 247 Intra-uterine death 1 1 0 Stillbirth 1 1 0 Foetal cardiac disorder 1 1 1 Foetal disorder 1 1 1 Foetal distress syndrome 1 0 1 Pre-eclampsia 1 0 1 Neonatal disorder 2 0 2 Meconium stain 1 0 1 25/09/2009-7 - 10:31:03 AM

Pregnancy, puerperium and perinatal conditions Pregnancy, puerperium and perinatal conditions 9 4 7 Psychiatric disorders Agitation 44 0 29 Agitation neonatal 1 0 1 Anxiety 28 0 17 Nervousness 6 0 3 Tension 1 0 1 Fear 1 0 0 Panic attack 5 0 4 Panic disorder 1 0 0 Neurosis 4 0 4 Restlessness 3 0 3 Automatism 1 0 0 Bruxism 8 0 6 Screaming 1 0 1 Confusional state 52 0 28 Disorientation 2 0 2 Delirium 8 0 2 Depression 8 0 5 Depersonalisation 9 0 9 Dissociation 1 0 0 Delusion 2 0 2 Hallucination 25 0 13 Hallucination, auditory 3 0 2 Hallucination, visual 2 0 2 Thinking abnormal 2 0 2 Eating disorder 1 0 0 Hypomania 1 0 1 Mania 10 0 8 Affect lability 3 0 2 Anger 2 0 1 Euphoric mood 1 0 1 Mood altered 2 0 1 Mood swings 3 0 2 Aggression 13 0 6 Homicidal ideation 5 0 1 Indifference 1 0 1 Paranoia 2 0 2 Violence-related symptom 1 0 0 Abnormal behaviour 4 0 1 Hypervigilance 1 0 1 Mental disorder 1 0 1 25/09/2009-8 - 10:31:03 AM

Psychiatric disorders Withdrawal syndrome 12 0 8 Acute psychosis 1 0 0 Psychotic disorder 2 0 2 Anorgasmia 4 0 4 Libido decreased 7 0 7 Insomnia 18 0 12 Sleep attacks 1 0 1 Abnormal dreams 1 0 1 Abnormal sleep-related event 2 1 0 Nightmare 17 0 12 Sleep disorder 6 0 5 Completed suicide 3 3 1 Intentional self-injury 1 0 1 Self injurious behaviour 1 0 1 Self-injurious ideation 1 0 0 Suicidal ideation 16 0 10 Suicide attempt 18 0 9 Psychiatric disorders 380 4 239 Renal and urinary disorders Tubulointerstitial nephritis 4 0 2 Anuria 1 0 0 Renal failure 2 0 2 Renal failure acute 5 0 1 Renal impairment 1 0 0 Renal tubular necrosis 1 0 1 Urethral disorder 1 0 0 Dysuria 3 0 2 Pollakiuria 3 0 2 Urethral pain 1 0 1 Urinary hesitation 2 0 1 Urinary incontinence 3 0 2 Urinary retention 5 0 4 Chromaturia 1 0 0 Haematuria 1 0 1 Nocturia 1 0 1 Polyuria 2 0 2 Renal pain 1 0 0 Renal and urinary disorders 38 0 22 Reproductive system and breast disorders Breast enlargement 1 0 1 Gynaecomastia 1 0 1 Breast pain 1 0 1 Galactorrhoea 6 0 6 Suppressed lactation 1 0 1 25/09/2009-9 - 10:31:03 AM

Reproductive system and breast disorders Premenstrual syndrome 1 0 1 Amenorrhoea 1 0 0 Penile size reduced 1 0 1 Penis disorder 1 0 1 Genital ulceration 1 0 1 Perineal pain 1 0 1 Ejaculation delayed 1 0 1 Ejaculation disorder 1 0 1 Ejaculation failure 3 0 3 Erectile dysfunction 9 0 6 Priapism 1 0 0 Sexual dysfunction 2 0 2 Uterine haemorrhage 1 0 1 Vaginal haemorrhage 1 0 1 Vulval ulceration 1 0 1 Vulval erythema 1 0 1 Reproductive system and breast disorders 37 0 32 Respiratory, thoracic and mediastinal disorders Asthma 2 0 1 Interstitial lung disease 1 0 1 Pulmonary fibrosis 1 0 1 Pulmonary hypertension 1 0 0 Pulmonary embolism 1 1 0 Apnoea 1 0 1 Dyspnoea 18 1 11 Hyperventilation 3 0 3 Hypoventilation 1 0 1 Respiratory depression 1 1 0 Hypoxia 2 1 0 Cough 9 0 8 Sputum increased 1 0 1 Hiccups 1 0 1 Respiratory failure 1 1 0 Aspiration 1 0 1 Respiratory disorder 2 0 2 Dysphonia 1 0 1 Sneezing 1 0 1 Snoring 1 0 1 Throat irritation 1 0 1 Yawning 3 0 3 Stridor 1 0 0 Nasal congestion 1 0 0 Epistaxis 1 0 1 25/09/2009-10 - 10:31:03 AM

Respiratory, thoracic and mediastinal disorders Nasal dryness 1 0 1 Pharyngeal oedema 1 0 1 Respiratory, thoracic and mediastinal disorders 59 5 42 Skin and subcutaneous tissue disorders Angioedema 5 0 5 Periorbital oedema 5 0 5 Urticaria 16 0 16 Mechanical urticaria 1 0 1 Blister 2 0 0 Dry skin 3 0 3 Skin burning sensation 1 0 1 Skin discolouration 1 0 1 Dermatitis 1 0 1 Drug eruption 1 0 1 Erythema 2 0 1 Rash erythematous 5 0 5 Dermatitis exfoliative 1 0 0 Exfoliative rash 1 0 1 Skin exfoliation 1 0 1 Lichen sclerosus 1 0 0 Rash papular 1 0 1 Photosensitivity reaction 1 0 1 Pruritus 21 0 14 Rash pruritic 2 0 2 Psoriasis 1 0 1 Fixed eruption 1 0 1 Rash 27 0 19 Rash generalised 1 0 0 Rash macular 1 0 0 Rash maculo-papular 5 0 2 Erythema nodosum 1 0 1 Acne 1 0 0 Alopecia 6 0 3 Cold sweat 2 0 1 Hyperhidrosis 43 1 27 Nail disorder 1 0 1 Henoch-Schonlein purpura 1 0 1 Increased tendency to bruise 1 0 1 Purpura 4 0 4 Skin and subcutaneous tissue disorders 168 1 122 Social circumstances Walking disability 1 0 0 Social circumstances 1 0 0 25/09/2009-11 - 10:31:03 AM

Surgical and medical procedures Abortion induced 1 1 1 Drug therapy changed 12 0 10 Therapy regimen changed 6 0 3 Surgical and medical procedures 19 1 14 Vascular disorders Peripheral ischaemia 2 0 1 Circulatory collapse 5 0 1 Hypotension 5 1 3 Orthostatic hypotension 4 0 1 Deep vein thrombosis 1 1 0 Flushing 6 0 4 Hot flush 5 0 4 Pallor 1 1 0 Hypertension 9 0 6 Arteritis 1 0 0 Vasculitis 1 0 0 Vascular disorders 40 3 20 1961 39 1276 25/09/2009-12 - 10:31:03 AM